Literature DB >> 25279395

Dental plaque, gingival inflammation and tooth -discolouration with different commercial -formulations of 0.2% chlorhexidine rinse: a double-blind randomised controlled clinical trial.

Filippo Graziani, Mario Gabriele, Francesco D'Aiuto, Jeanie Suvan, Matteo Tonelli, Silvia Cei.   

Abstract

PURPOSE: To investigate the efficacy of various formulations of chlorhexidine 0.2% (CHX) in terms of plaque and gingival bleeding control compared to each other and to saline rinse (CTRL) over a 35-day rinsing period.
MATERIALS AND METHODS: Seventy subjects were randomly allocated to one of 4 groups rinsing twice daily for 35 days. The different groups used CHX 0.2% rinse with alcohol (CHX1) and without alcohol (CHX2), with an antidiscolouration system (CHX3) or saline rinse (CTRL). Clinical examinations to evaluate full-mouth plaque scores (FMPS) and periodontal parameters were performed at baseline, 7, 21 and 35 days. Tooth discolouration (TD) was measured at each time point using digital photographs and spectrophotometric analysis.
RESULTS: At 35 days, CTRL showed the highest levels of plaque. The mean changes in FMPS from baseline were 69.8% ± 6.8 for CHX1, 57.5% ± 9.8 for CHX2, 43.7% ± 9.8 for CHX3 and 25.8% ± 7.7 for CTRL. Statistically significant differences were demonstrated between CHX1 and CHX3 (p = 0.02), CHX2 vs CHX3 (p ≤ 0.05) and CHX1/CHX2 vs CHX3 (p < 0.05). In contrast, CHX3 appeared more effective in reducing inflammatory indexes. TD increased over time in 60% to 70% of participants, although lighter staining was found in the CHX3 group. Greater FMPS reduction was observed in participants with staining vs without staining (26.0% ± 12.3, p = 0.04).
CONCLUSION: Conventional CHX appeared more effective in terms of plaque reduction. Interestingly, the newest formulation showed a higher control of gingival inflammation. Staining was associated with lower plaque levels.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25279395     DOI: 10.3290/j.ohpd.a32827

Source DB:  PubMed          Journal:  Oral Health Prev Dent        ISSN: 1602-1622            Impact factor:   1.256


  6 in total

Review 1.  Chlorhexidine mouthrinse as an adjunctive treatment for gingival health.

Authors:  Patrice James; Helen V Worthington; Carmel Parnell; Mairead Harding; Thomas Lamont; Andrea Cheung; Helen Whelton; Philip Riley
Journal:  Cochrane Database Syst Rev       Date:  2017-03-31

2.  Alcohol-free essential oils containing mouthrinse efficacy on three-day supragingival plaque regrowth: a randomized crossover clinical trial.

Authors:  Enrico Marchetti; Simona Tecco; Eleonora Caterini; Fabio Casalena; Vincenzo Quinzi; Antonella Mattei; Giuseppe Marzo
Journal:  Trials       Date:  2017-03-31       Impact factor: 2.279

Review 3.  Adverse events associated with home use of mouthrinses: a systematic review.

Authors:  Gianluca M Tartaglia; Santosh Kumar Tadakamadla; Stephen Thaddeus Connelly; Chiarella Sforza; Conchita Martín
Journal:  Ther Adv Drug Saf       Date:  2019-09-23

4.  In Vitro Evaluation of Substantivity, Staining Potential, and Biofilm Reduction of Guava Leaf Extract Mouth Rinse in Combination with its Anti-Inflammatory Effect on Human Gingival Epithelial Keratinocytes.

Authors:  Jothi Varghese; Liza L Ramenzoni; Padamaja Shenoy; Usha Y Nayak; Namrata Nayak; Thomas Attin; Patrick R Schmidlin
Journal:  Materials (Basel)       Date:  2019-11-26       Impact factor: 3.623

5.  Comparison of 0.2% chlorhexidine mouthwash with and without anti-discoloration system in patients with chronic periodontitis: A randomized controlled clinical trial.

Authors:  Siamak Yaghobee; Farid Abedin Dorkoosh; Farnaz Kouhestani; Ghazaleh Mozafari; Hoori Aslroosta
Journal:  J Adv Periodontol Implant Dent       Date:  2019-12-18

6.  Does chlorhexidine mouthwash, with an anti-discoloration system, reduce tooth surface discoloration without losing its efficacy? A systematic review and meta-analysis.

Authors:  Bregje W M Van Swaaij; G A Fridus van der Weijden; Eric W P Bakker; Filippo Graziani; Dagmar E Slot
Journal:  Int J Dent Hyg       Date:  2019-08-01       Impact factor: 2.477

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.